A detailed history of Hayek Kallen Investment Management transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Hayek Kallen Investment Management holds 11,863 shares of AVXL stock, worth $102,377. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,863
Previous 11,863 -0.0%
Holding current value
$102,377
Previous $50,000 34.0%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$3.39 - $5.02 $1,830 - $2,710
540 Added 4.77%
11,863 $50,000
Q1 2024

May 03, 2024

BUY
$4.55 - $6.75 $2,957 - $4,387
650 Added 6.09%
11,323 $58,000
Q4 2023

Feb 08, 2024

BUY
$5.04 - $9.95 $53,791 - $106,196
10,673 New
10,673 $99,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $673M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Hayek Kallen Investment Management Portfolio

Follow Hayek Kallen Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.